Platelet-rich Plasma Therapy Market Insights, Global Outlook and Forecast 2022-2028
Platelet-rich Plasma Therapy Market Insights, Global Outlook and Forecast 2022-2028
The Global Platelet rich Plasma Therapy Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
The latest research study released by Market IntelliX evaluates market size and forecasts of Platelet-rich Plasma Therapy in Global, including the following market information:
Global Platelet-rich Plasma Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Platelet-rich Plasma Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pure PRP Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Platelet-rich Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics and Weigao, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Platelet-rich Plasma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Platelet-rich Plasma Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Type, 2021 (%)
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Global Platelet-rich Plasma Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Application, 2021 (%)
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others
Global Platelet-rich Plasma Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platelet-rich Plasma Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Platelet-rich Plasma Therapy revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Platelet-rich Plasma Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Platelet-rich Plasma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Platelet-rich Plasma Therapy Overall Market Size
2.1 Global Platelet-rich Plasma Therapy Market Size: 2021 VS 2028
2.2 Global Platelet-rich Plasma Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Platelet-rich Plasma Therapy Players in Global Market
3.2 Top Global Platelet-rich Plasma Therapy Companies Ranked by Revenue
3.3 Global Platelet-rich Plasma Therapy Revenue by Companies
3.4 Top 3 and Top 5 Platelet-rich Plasma Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Platelet-rich Plasma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Platelet-rich Plasma Therapy Players in Global Market
3.6.1 List of Global Tier 1 Platelet-rich Plasma Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Platelet-rich Plasma Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Platelet-rich Plasma Therapy Market Size Markets, 2021 & 2028
4.1.2 Pure PRP
4.1.3 Leucocyte-rich PRP
4.1.4 Leukocyte-rich Fibrin (L-PRF)
4.2 By Type - Global Platelet-rich Plasma Therapy Revenue & Forecasts
4.2.1 By Type - Global Platelet-rich Plasma Therapy Revenue, 2017-2022
4.2.2 By Type - Global Platelet-rich Plasma Therapy Revenue, 2023-2028
4.2.3 By Type - Global Platelet-rich Plasma Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Platelet-rich Plasma Therapy Market Size, 2021 & 2028
5.1.2 Orthopedic
5.1.3 Darmatology
5.1.4 Cardiac Muscle Injury
5.1.5 Dental
5.1.6 Nerve Injury
5.1.7 Others
5.2 By Application - Global Platelet-rich Plasma Therapy Revenue & Forecasts
5.2.1 By Application - Global Platelet-rich Plasma Therapy Revenue, 2017-2022
5.2.2 By Application - Global Platelet-rich Plasma Therapy Revenue, 2023-2028
5.2.3 By Application - Global Platelet-rich Plasma Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Platelet-rich Plasma Therapy Market Size, 2021 & 2028
6.2 By Region - Global Platelet-rich Plasma Therapy Revenue & Forecasts
6.2.1 By Region - Global Platelet-rich Plasma Therapy Revenue, 2017-2022
6.2.2 By Region - Global Platelet-rich Plasma Therapy Revenue, 2023-2028
6.2.3 By Region - Global Platelet-rich Plasma Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Platelet-rich Plasma Therapy Revenue, 2017-2028
6.3.2 US Platelet-rich Plasma Therapy Market Size, 2017-2028
6.3.3 Canada Platelet-rich Plasma Therapy Market Size, 2017-2028
6.3.4 Mexico Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Platelet-rich Plasma Therapy Revenue, 2017-2028
6.4.2 Germany Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.3 France Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.4 U.K. Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.5 Italy Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.6 Russia Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Platelet-rich Plasma Therapy Market Size, 2017-2028
6.4.8 Benelux Platelet-rich Plasma Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Platelet-rich Plasma Therapy Revenue, 2017-2028
6.5.2 China Platelet-rich Plasma Therapy Market Size, 2017-2028
6.5.3 Japan Platelet-rich Plasma Therapy Market Size, 2017-2028
6.5.4 South Korea Platelet-rich Plasma Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Platelet-rich Plasma Therapy Market Size, 2017-2028
6.5.6 India Platelet-rich Plasma Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Platelet-rich Plasma Therapy Revenue, 2017-2028
6.6.2 Brazil Platelet-rich Plasma Therapy Market Size, 2017-2028
6.6.3 Argentina Platelet-rich Plasma Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Platelet-rich Plasma Therapy Revenue, 2017-2028
6.7.2 Turkey Platelet-rich Plasma Therapy Market Size, 2017-2028
6.7.3 Israel Platelet-rich Plasma Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Platelet-rich Plasma Therapy Market Size, 2017-2028
6.7.5 UAE Platelet-rich Plasma Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Terumo
7.1.1 Terumo Corporate Summary
7.1.2 Terumo Business Overview
7.1.3 Terumo Platelet-rich Plasma Therapy Major Product Offerings
7.1.4 Terumo Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.1.5 Terumo Key News
7.2 Arthrex
7.2.1 Arthrex Corporate Summary
7.2.2 Arthrex Business Overview
7.2.3 Arthrex Platelet-rich Plasma Therapy Major Product Offerings
7.2.4 Arthrex Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.2.5 Arthrex Key News
7.3 Zimmer Biomet
7.3.1 Zimmer Biomet Corporate Summary
7.3.2 Zimmer Biomet Business Overview
7.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Major Product Offerings
7.3.4 Zimmer Biomet Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.3.5 Zimmer Biomet Key News
7.4 DePuy Synthes
7.4.1 DePuy Synthes Corporate Summary
7.4.2 DePuy Synthes Business Overview
7.4.3 DePuy Synthes Platelet-rich Plasma Therapy Major Product Offerings
7.4.4 DePuy Synthes Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.4.5 DePuy Synthes Key News
7.5 EmCyte
7.5.1 EmCyte Corporate Summary
7.5.2 EmCyte Business Overview
7.5.3 EmCyte Platelet-rich Plasma Therapy Major Product Offerings
7.5.4 EmCyte Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.5.5 EmCyte Key News
7.6 Regen Lab
7.6.1 Regen Lab Corporate Summary
7.6.2 Regen Lab Business Overview
7.6.3 Regen Lab Platelet-rich Plasma Therapy Major Product Offerings
7.6.4 Regen Lab Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.6.5 Regen Lab Key News
7.7 ISTO Biologics
7.7.1 ISTO Biologics Corporate Summary
7.7.2 ISTO Biologics Business Overview
7.7.3 ISTO Biologics Platelet-rich Plasma Therapy Major Product Offerings
7.7.4 ISTO Biologics Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.7.5 ISTO Biologics Key News
7.8 Cesca Therapeutics
7.8.1 Cesca Therapeutics Corporate Summary
7.8.2 Cesca Therapeutics Business Overview
7.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Major Product Offerings
7.8.4 Cesca Therapeutics Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.8.5 Cesca Therapeutics Key News
7.9 Weigao
7.9.1 Weigao Corporate Summary
7.9.2 Weigao Business Overview
7.9.3 Weigao Platelet-rich Plasma Therapy Major Product Offerings
7.9.4 Weigao Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.9.5 Weigao Key News
7.10 REV-MED
7.10.1 REV-MED Corporate Summary
7.10.2 REV-MED Business Overview
7.10.3 REV-MED Platelet-rich Plasma Therapy Major Product Offerings
7.10.4 REV-MED Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.10.5 REV-MED Key News
7.11 Nuo Therapeutics
7.11.1 Nuo Therapeutics Corporate Summary
7.11.2 Nuo Therapeutics Business Overview
7.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Major Product Offerings
7.11.4 Nuo Therapeutics Platelet-rich Plasma Therapy Revenue in Global Market (2017-2022)
7.11.5 Nuo Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Platelet rich Plasma Therapy Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|